India and South Africa are pressing the World Trade Organization to waive patent rights to help ramp up vaccine production. There's a better solution.
Vaccine manufacturing is complex, with lots of potential points for errors. But it also has extensive quality control checks and approvals.
COVID-19 vaccine testing on children is just getting started, and only in adolescents.
In the 1980s, CSIRO and its university collaborators set into motion a chain of events that would lead to the production of relenza, the first drug to successfully treat the flu.
Inspired by amber and hard candy, researchers figured out a new, needle-free, shelf-stable way to preserve vaccines, making them easier to ship and administer around the world.